Ryanair share price rebounding but aviation stocks continue to struggle
It’s been a tough time for airlines over the past few years. A not-so-friendly pandemic grounded planes for the best part of two
It’s been a tough time for airlines over the past few years. A not-so-friendly pandemic grounded planes for the best part of two
Anheuser-Busch (NYSE: BUD) stock price has retreated in the past few days as investors focus on the ongoing Dylan Mulvaney controversy. The
The SCHD ETF stock price has made a spectacular recovery in the past two weeks as the American banking crisis eased. The
De La Rue (LON: DLAR), the giant banknote printer, issued its third profit warning since January 2022 as demand for cash slumped
IDS (LON: IDS) share price has moved sideways in the past few weeks as concerns about the company remains elevated. Shares of
Exxon stock (NYSE: XOM) has turned green after news emerged that Exxon Mobil Corp is in potential acquisition talks with oil
Argo Blockchain (LON: ARB) share price has moved sideways in the past few days even after Bitcoin surged to the highest level
AMTD Idea (NYSE: AMTD) stock price jumped sharply this week as a short-squeeze happened ahead of the upcoming earnings. The stock jumped
AT&T (NYSE: T) stock price has recovered modestly from its lowest level in 2022 as investors move on past the company’s dividend
The GDX ETF stock is doing well as gold prices approach their all-time high and as investors slowly embrace a risk-on sentiment.
The SPY ETF stock has done modestly well in the past few weeks as concerns about the banking sector ease. The SPDR
BP plc (LON: BP) ended in the green today after announcing an agreement with Harbour Energy PLC (LON: HBR) to develop the
LendingClub Corp (NYSE: LC) will offer lucrative returns if the U.S. economy avoids a severe recession, says Reginald Smith. He’s an Analyst
SOL, the native token of Solana, has seen double digit gains in the past 24 hours as bulls turn up ahead of
“IMF” – the International Monetary Fund says global economic growth will remain around 3.0% over the next five years – its weakest
Shares of Moderna Inc (NASDAQ: MRNA) are trading down on Tuesday after the biotechnology company said it did not have enough data